Buzzing Stocks
« Previous EntriesGlenmark receives ANDA approval from U.S. FDA for Hydralazine Hydrochloride Tablets
Monday, June 1st, 2009Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release
dated June 01, 2009 titled “Glenmark receives ANDA approval from U.S.
FDA for Hydralazine Hydrochloride Tablets”.
Religare and Swiss Re join hands to enter India health insurance space
Monday, June 1st, 2009Religare Enterprises Ltd has informed BSE regarding a Press Release
dated June 01, 2009 titled “Religare and Swiss Re join hands to enter
India health insurance space”.
Parsvnath gets approval for Parsvnath La Tropicana
Monday, June 1st, 2009Parsvnath Developers Ltd has informed BSE regarding a Press Release
dated June 01, 2009 titled “Parsvnath gets approval for Parsvnath La
Tropicana; Premium luxury project in the heart of Delhi worth Rs 1300
Crores”
Aurobindo Pharma receives approval for Terbinafine Tablets
Wednesday, December 24th, 2008
Aurobindo Pharma Ltd has informed BSE regarding a Press Release dated December 24, 2008 titled “Aurobindo Pharma receives approval for Terbinafine Tablets from Health Canada”. They also have quoted that this drug has got approval for 125 mg and 250 mg tablets which are mainly used for the fungal infections of skin and nails.
The stock has reacted quite very nicelyand is currently trading nearly 4% up at 155.28 Rs.
Areva T&D Board approves Sub-division of equity shares
Tuesday, July 29th, 2008Areva T&D India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 29, 2008, inter alia, has approved the Sub-division of Equity Shares of Rs 10/- each into 5 Equity Shares of Rs 2/- each, subject to the approval of the Shareholders by the Postal Ballot.
The Company has appointed Mr. P V Subramanian, a Practicing Company Secretary, as Scrutinizer for conducting the Postal Ballot process in a fair and transparent manner.
Bliss GVS Board Bonus Issue consideration on 29 July
Wednesday, July 23rd, 2008Bliss GVS Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on July 29, 2008, inter alia, to consider the Audited Financial Result for the year ended March 31, 2008, the Un-audited Financial Results for the Quarter ended June 30, 2008 and to consider the declaration of Bonus Shares. The Board will decide the ratio and record date for the same.
Colgate Palmolive net profit up 100 crores for Q1 Fy08
Thursday, July 17th, 2008Colgate Palmolive India Ltd has announced the following Unaudited results for the quarter ended June 30, 2008:
The Company has posted a net profit after tax of Rs 719.20 million for the quarter ended June 30, 2008 as compared to Rs 608.80 million for the quarter ended June 30, 2007. Total Revenue has increased from Rs 3716.50 million for the quarter ended June 30, 2007 to Rs 4387.70 million for the quarter ended June 30, 2008.
IFCI Announces Q1 FY08 reults
Monday, July 14th, 2008IFCI has just come up with their financial result for quarter eneding June 2008 and have posted net profit of Rs.151 crore which almost down 38% from previous year same quarter. And also its other incomes were sunstaintially low compared to last year same quarter.
Stock also reacted badly to the results and is down nearly 6% and trading at 37.40 on BSE.
Sejal Architectural Glass IPO Subscription Details
Friday, June 13th, 2008Sejal Architectural Glass IPO which closed yesterday for subscription have received very good response from all sorts of investors. Initial public review by many brokerages was not hat much impressive and looking at the market conditions right now, this is considered to be very good subscription data.
Subscription details are as follow:
1 Qualified Institutional Buyers (QIBs) 4.2628
2 Non Institutional Investors 33.17151
3 Retail Individual Investors (RIIs) 7.9791
Punj Lloyd down 7%
Tuesday, June 10th, 2008Punj Lloyd was under considerable pressure in the late trade today and have lost nearly 7% from its days high of 263. Right now it is trading at Rs 241. Majority of reality giants like GMR, Unitech, JP Associate are down more than 5%. Advice is to stay away from reality and banking right now. Buying opportunity will arise latter this month.
« Previous Entries